Axcynsis Therapeutics

About Axcynsis Therapeutics

The startup develops a biotechnology platform that focuses on Antibody-X Conjugate (AXC) therapies specifically designed for cancer treatment. Their pipeline of AXC candidates targets unmet medical needs by providing new therapeutic options for various cancer types.

What does Axcynsis Therapeutics do?

The startup develops a biotechnology platform that focuses on Antibody-X Conjugate (AXC) therapies specifically designed for cancer treatment. Their pipeline of AXC candidates targets unmet medical needs by providing new therapeutic options for various cancer types.

Where is Axcynsis Therapeutics located?

Axcynsis Therapeutics is based in Singapore.

When was Axcynsis Therapeutics founded?

Axcynsis Therapeutics was founded in 2022.

How much funding has Axcynsis Therapeutics raised?

Axcynsis Therapeutics has raised 21000000.

Who founded Axcynsis Therapeutics?

Axcynsis Therapeutics was founded by ZOU BIN.

  • ZOU BIN - CEO
Location
Singapore
Founded
2022
Funding
21000000
Employees
11 employees
Looking for specific startups?
Try our free semantic startup search

Axcynsis Therapeutics

Score: 99/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

The startup develops a biotechnology platform that focuses on Antibody-X Conjugate (AXC) therapies specifically designed for cancer treatment. Their pipeline of AXC candidates targets unmet medical needs by providing new therapeutic options for various cancer types.

axcynsis.com1K+
Founded 2022 – Singapore

Funding

$

Estimated Funding

$21M+

Team (10+)

ZOU BIN

CEO